The promise of individualized medicine — where tests and therapies are tailored to each patient’s precise genetic makeup — is becoming a reality for cardiology patients at the University of Maryland Medical Center (UMMC), the culmination of efforts to determine which blood thinner will work best for each patient at preventing blood clots that cause heart attacks and sustaining health.